Efficacy of lattice laser combined with transdermal administration of halomethasone in treating hypertrophic scars
10.3760/cma.j.issn.1671-0290.2020.02.019
- VernacularTitle:点阵激光联合卤米松乳膏透皮给药治疗增生性瘢痕的疗效
- Author:
Xin DU
1
;
Chunjun YANG
Author Information
1. 安徽医科大学第二附属医院皮肤性病科，合肥 230001
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2020;26(2):142-144
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and effectiveness of dot matrix laser combined with transdermal administration in the treatment of hypertrophic scars.Methods:From January 2014 to December 2019, 123 patients with hypertrophic scars in the Dermatology Clinic, the Second Affiliated Hospital of Anhui Medical University. Observation group included 63 cases, 30 males and 33 females, aged 7 to 69 (31.7±14.6) years; given lomatasone cream for topical application, once in the morning and evening, combined with lattice laser transdermal administration, once a week for 3 months. There were 60 patients in the control group, 28 males and 32 females, aged 10-71 (32.8±15.1) years; topical lomidasone cream was given, one morning and one evening, with a course of 3 months.Results:Clinical trials were completed in 123 patients. The total effective rate in the observation group was 66.7% (42/63), of which 18 cases were cured, and 18 cases were markedly effective; 6 cases were effective, 21 cases were ineffective; the total effective rate in the control group was 20.0% (12/60), of which 0 cases were cured, and the effect was 7 Cases, and 5 cases were effective, 48 cases were ineffective. The effective rate of the observation group was significantly better than that of the control group ( P<0.05), and there were no adverse reactions in the observation group. Conclusions:Lattice laser transdermal administration combined with halomethasone cream for topical treatment of hypertrophic scars is effective, safe, and worthy of clinical application.
